Guanfacine hydrochloride


( Last Updated : August 27, 2013)
Generic Name:
Guanfacine hydrochloride
Project Status:
Complete
Therapeutic Area:
Attention-deficit/hyperactivity disorder (ADHD)
Manufacturer:
Shire Canada Inc.
Call for patient/clinician input open:
Brand Name:
Intuniv XR
Project Line:
Reimbursement Review
Project Number:
SR0349-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Attention-deficit/hyperactivity disorder (ADHD)
Recommendation Type:
Do not list
Final Recommendation: